Did Roger Marshall buy Intra-Cellular Therapies stock?

Common questions

Did Roger Marshall buy Intra-Cellular Therapies stock?

Yes. Roger Marshall disclosed 1 purchase of Intra-Cellular Therapies (ITCI) stock on May 1, 2017, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.

How big were Roger Marshall's Intra-Cellular Therapies trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.

Did Roger Marshall make these Intra-Cellular Therapies trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Roger Marshall still own Intra-Cellular Therapies stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Roger Marshall report these trades?

The latest filing is dated Aug 6, 2018. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.